OBIO — Early Adopter Health Network (EAHN)
ON, Canada
Partnerships for Canadian health technology companies
grant_single_labels|summary
grant_single|eligibleFinancing
- grant_single|noCondition
grant_single|deadlines
- grant_single|openingDateAugust 01, 2022
grant_single|financingType
Wage Subsidies And Interns
Expert Advice
grant_single|eligibleIndustries
- Health care and social assistance
grant_single|grantors
- Ontario Bioscience Innovation Organization (OBIO)
grant_single|status
grant_card_status|open
grant_single_labels|preview
Get access to partnership opportunities for your Canadian health technology company through a network of Ontario health organizations to evaluate technologies in real-world setting and to facilitate their broad adoption into the health system.
grant_single_labels|projects
There are activities eligible for this grant. The OBIO® EAHN™ program supports Canadian health technology companies and healthcare organizations in evaluating technologies, facilitating their adoption into the health system, and providing financial support during the evaluation.
- Evaluation and adoption of innovative healthcare technologies
- Collaboration between health technology companies and healthcare organizations
- Financial support for technology evaluation
- Facilitation of technology adoption into the health system
grant_single|admissibleProjectsExample
$70,000
Evaluation of a digital mental health app
$80,000
Adoption of telemedicine platform in a Calgary clinic
$70,000
Pilot study of a wearable cardiac monitor
$100,000
Trial of a robotic surgery assistant in a Winnipeg hospital
$75,000
Adoption of a smart pill dispenser in an Ottawa senior care home
grant_single_labels|admissibility
Eligibility for participation in the EAHN™ program is implied for Canadian health technology companies, but explicit criteria are not detailed in the provided information.
- Companies must be considered Canadian health technology companies.
grant_eligibility_criteria|who_can_apply
Canadian health technology companies and healthcare organizations who are part of or wish to engage with the Early Adopter Health Network (EAHN™) can apply. The program is structured to support the real-world evaluation of technologies and foster industry-driven partnerships within the Canadian health sector. Collaborative participation in the program is encouraged from companies, healthcare organizations, and ecosystem partners dedicated to improving patient care, provider satisfaction, and system efficiencies through innovative technologies.
grant_eligibility_criteria|eligible_expenses
The OBIO EAHN program supports projects that bridge Canadian health technology companies with healthcare organizations to evaluate and integrate innovative technologies into the health system. Eligible activities focus on the real-world assessment of technologies and their broad dissemination and demonstration globally.
- Evaluation of health technologies in real-world settings.
- Partnership development between technology companies and healthcare organizations.
- Dissemination of value-producing technologies within the health system.
- Creation of showcase sites for successful technologies.
- Support for technology enhancements based on evaluation feedback.
grant_single_labels|criteria
The OBIO's Early Adopter Health Network (EAHN™) program has evaluation and selection criteria for companies seeking financial support:
- Demonstrated potential to improve patient care, provider satisfaction, and system efficiency.
- Evidence of innovation and value-producing technologies.
- Strong interest in advancing Canadian healthcare solutions.
grant_single_labels|register
- Step 1: Preliminary Engagement
- Contact OBIO to express interest in the EAHN™ program and determine eligibility.
- Discuss partnership objectives with OBIO to align project goals with program expectations.
- Step 2: Develop Partnership
- Identify and establish partnerships with appropriate healthcare organizations through OBIO’s network.
- Collaborate with partners to outline evaluation methodologies and expected outcomes.
- Step 3: Application Preparation
- Prepare a detailed application including company profile, technology details, and partnership agreements.
- Include specific project plans, evaluation strategies, and anticipated impacts on healthcare delivery.
- Step 4: Submit Application
- Submit the completed application and all required supporting documentation to OBIO through the provided channels.
- Ensure all aspects of the application are aligned with the program’s goals and requirements.
- Step 5: Follow-up and Review
- OBIO reviews the application and provides feedback or requests further information if necessary.
- Engage with OBIO for any required clarifications or adjustments to the proposal.
- Step 6: Confirmation and Next Steps
- Upon acceptance, receive a confirmation and outline of next steps for project initiation.
- Begin collaborative projects and evaluations as per the agreed plan.
grant_single_labels|otherInfo
Here are additional relevant details for this grant:
- EAHN™ provides a platform for both showcasing successful Canadian healthcare technologies and facilitating their global market access.
- The program encourages partnerships that can demonstrate the value of Canadian health innovations both locally and internationally.
- Participation in the EAHN™ program may bolster a company’s profile and facilitate access to further funding opportunities.
- The program facilitates connections with national and regional innovation partners, providing additional support and resources for technology adoption.
- Participants may benefit from engagement with Canadian healthcare networks to validate and optimize technology solutions before going international.
Apply to this program
Enhancing Healthcare with Canadian Innovations
The OBIO® Early Adopter Health Network (EAHN™) provides a platform for Canadian health technology companies to collaborate with healthcare organizations, evaluating innovative solutions in real-world scenarios. This grant program aims to accelerate the adoption of promising technologies, improve healthcare delivery, and bolster Canada's position in the global health innovation market.
Unveiling the Impact of the OBIO® EAHN™ Program
The OBIO® Early Adopter Health Network (EAHN™) stands at the forefront of fostering innovation in the Canadian healthcare system by creating synergies between health technology companies and healthcare organizations. This initiative plays a crucial role in evaluating cutting-edge technologies within actual healthcare settings, offering a unique opportunity for these technologies to be integrated seamlessly into the health system. The financial backing provided by the EAHN™ program supports both companies and healthcare institutions during the evaluation phase, ensuring that the technologies proving their value can reach a wider audience efficiently.
Canadian health technology companies benefit profoundly from engaging with the EAHN™ network. The program facilitates access to a network of healthcare organizations willing and equipped to test innovative solutions, helping providers improve patient care and operational efficiency. By successfully undergoing real-world evaluations, these companies not only prove the efficacy of their solutions but also position themselves favorably in the competitive global marketplace. This exposure is invaluable, boosting their credibility and helping them attract further investment, as exemplified by companies like Flosonics Medical, for whom participation in the program was pivotal during their recent financing round.
Healthcare organizations partaking in the EAHN™ program are empowered to enhance their service delivery significantly. The program enables them to access advanced, commercial-ready technologies that have already been pre-vetted, allowing them to focus on assessing these technologies' value. This approach aligns with the strategic goals of increasing efficiency and satisfaction within the healthcare system, as demonstrated by the experiences of institutions like Southlake Regional Health Centre and the University Health Network. The program supports a value-based procurement process centered around technologies that match the unique requirements and challenges of the Canadian healthcare landscape.
Additionally, the EAHN™ program collaborates with ecosystem partners at both national and regional levels to ensure that the necessary resources, support mechanisms, and strategic guidance are available to all participants. These partnerships facilitate the smooth adoption and dissemination of technologies that have been demonstrated to yield substantial benefits in patient outcomes and healthcare efficiency.
The significance of the EAHN™ program extends beyond immediate healthcare improvements; it presents Canada as a leader in health innovation on the world stage. By creating showcase sites that highlight the success of Canadian technologies, the program not only enhances the global reputation of participating companies but also attracts international interest in Canada's innovative healthcare solutions. This global engagement is a critical aspect of the program's success, ensuring that Canadian technologies meet international standards and expectations.
In summary, the OBIO® EAHN™ program is a transformative initiative for Canadian health technology companies and healthcare organizations. By aligning innovative Canadian solutions with real-world healthcare needs and providing a structured platform for evaluation and dissemination, the program significantly contributes to the enhancement of Canada's healthcare system. It supports a broad adoption of technologies that improve patient care and system efficiency, creating a win-win scenario for all involved stakeholders while solidifying Canada’s role as a pioneering leader in global healthcare innovation.
